Medulloblastoma

Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors

Rare CNS Tumors Outcomes &Risk

Accurate Diagnosis and Grading of Pediatric Solid Tumors Based on Pathological Large Models

Atovaquone Combined With Radiation in Children With Malignant Brain Tumors

Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors

PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications

AI-Assisted MRI Molecular Subtyping in Pediatric Brain Tumors

PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma

Targeting MYC in High-Risk Medulloblastoma

Digoxin Medulloblastoma Study

CSIMEMPHIS: Long-term Follow-up of Medulloblastoma Survivors That Received Craniospinal Irradiation

Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors

Phase I Study of APX005M in Pediatric Central Nervous System Tumors

Parental Distress and Treatment Adherence in Pediatric Recurrent Medulloblastoma

Methionine PET/CT Studies In Patients With Cancer

Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma

Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET

Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).